Stockreport

2seventy bio completes $40m haemophilia A program deal with Novo Nordisk [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF 2seventy bio will potentially receive up to $40m under the deal, which brings an end to a research agreement established between the companies in 2019. The deal focused [Read more]